| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000026461 |
| Receipt No. | R000030398 |
| Official scientific title of the study | Randomized placebo controlled Phase III trial to evaluate the reduction effects of functional foods (AHCC) on the adverse effects of digestive tract cancer chemotherapies and the investigation of the measurement method of cacogeusia |
| Date of disclosure of the study information | 2017/03/08 |
| Last modified on | 2017/03/08 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Randomized placebo controlled Phase III trial to evaluate the reduction effects of functional foods (AHCC) on the adverse effects of digestive tract cancer chemotherapies and the investigation of the measurement method of cacogeusia | |
| Title of the study (Brief title) | Phase III study of functional foods (AHCC) for reduction of adverse effects of digestive tract cancer chemotherapies. | |
| Region |
|
|
| Condition | |||||
| Condition | digestive tract cancer | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | Comparing investigation of the ameliorating effecs of functional foods (AHCC) on the adverse effects and cacogeusia caused by digestive tract cancer chemotherapy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Evaluation for adverse effects and taste disturbance of chemotherapy |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Functional food (AHCC): fixed dose | |
| Interventions/Control_2 | Non of Functional food (AHCC) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Digestive tract cancer patients treated with various chemotherapies
2)Aged 20 to 80 years old 3)Patients with no AHCC use history until start of this trial 4)Sufficient oral intake 5)Adequate organ functions 6)ECOG PS of 0 or 1 7)Written informed consent |
|||
| Key exclusion criteria | 1) Continuous use of other functional foods
2) Serious complicating disorders (hepatic cirrhosis, insulin administration-diabetes, cardiac disease, interstitial lung disease, kidney disease, DIC, anemia) 3) Immunodeficiency, immunedepression 4) Pregnant or nursing women 5) Past medical history of drug allergies 6) Active infectious disease 7) Past medical history of alcoholic intoxications and mental disorders 8) Inappropriate for this study judged by the attending physician 9) Under 20 years old and the adults with no capacity of judgment |
|||
| Target sample size | 240 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Yanagimoto |
| Organization | Kansai Medical University |
| Division name | Surgery Division |
| Address | 2-5-1,Shinmachi,Hirakata,Osaka 573-1191, Japan |
| TEL | 072-804-0101 |
| yanagimh@hirakata.kmu.ac.jp | |
| Public contact | |
| Name of contact person | Satoshi Hirooka |
| Organization | Kansai Medical University |
| Division name | Surgery Division |
| Address | 2-5-1,Shinmachi,Hirakata,Osaka 573-1191, Japan |
| TEL | 072-804-0101 |
| Homepage URL | |
| tomot1226@yahoo.co.jp | |
| Sponsor | |
| Institute | Kansai Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Amino Up Chemical Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030398 |